Consumerinjurylawyers:avandia Linked To Heart Attacks

By Author: s
Total Articles: 62
Comment this article

Government Reports Link Avandia to Heart Attacks:

The New York Times recently acquired confidential government reports that Avandia, manufactured by GlaxoSmithKline (GSK), is linked to an increased rate of heart problems. According to the government reports, if patients using Avandia for the treatment of type-2 diabetes were to switch to a different diabetes medication, approximately 500 heart attacks and 300 incidences of heart failure a month could be avoided.

According to the Institute for Safe Medical Practice, Avandia ranks number one among all prescription drugs in reports of serious side effects and fatalities.

GSK's Own Clinical Trials Link Avandia to Heart Attacks:

GlaxoSmithKline has completed a number of clinical trials over the years that have provided data indicating that Avandia is linked to an increased rate of heart problems. Based on this data, the World Health Organization sent a warning to GSK about Avandia. GSK was consequently ordered by European regulators to review earlier data from their clinical trials to provide a definitive report. This new report demonstrated that the ...
... risk of heart problems increased by one third when taking this drug. In spite of this, GSK continues to market and advertise Avandia.

Senate Investigates Heart Attack Risk of Avandia:

Reports of earlier clinical trials from GSK were finally provided to the Senate Committee for review. Even though GSK's clinical trials and reports indicated an increased risk of heart problems, GSK denied their own reports. The Senate Committee and the FDA criticized GSK, saying they should have warned patients years earlier that Avandia was potentially deadly. GSK responded to these accusations by intimidating physicians who spoke out about Avandia side effects. GSK provided these physicians with misinformation about the data it had collected, essentially downplaying its own clinical trials. GSK has been asked to run new clinical trials to test for increased heart problems but these trials won't be complete until 2020. GSK's patent will run out long before the trials are complete, and other pharmaceutical companies will be selling this potentially dangerous product.

Some FDA Officials Want Avandia to be Withdawn:

The FDA also expressed concern over the fact that the patients in this new trial have not been warned about the increased rate of heart attack with Avandia. There is fierce debate within the FDA, with some officials advocating that Avandia be withdrawn from the market.

If you have experienced a heart attack, or any other heart related illness while on Avandia, you may be entitled to financial compensation. Avandia Lawsuits are currently being filed across the country.

Author Bio.

Susan Ardizzoni, Ph.D holds a Doctorate in Biology with a major in Neuroscience (medical) and minors in Biochemistry, Physics, and Mathematics with experience in basic and clinical research.
Although the author is not an attorney, this article was sponsored by the law firm of Bernstein Liebhard LLP and constitutes Attorney Advertising. To learn more about Avandia Lawyer or Avandia Lawsuit please visit www.ConsumerInjuryLawyers.com